HIV/AIDS Clinical Trials

Showing 1461-1480 of 1,802 trials

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

NCT00414518

The purpose of this study is to determine the safety and effectiveness of an anti-HIV drug regimen followed by treatment interruption in people recently infected with HIV. This study will also compare the effects of a treatment regimen including treatment interruption with a treatment plan based on clinical indicators.

HIV Infections

University of Colorado, Denver16 participantsStarted Jan 2007

Denver, Colorado, United States • Atlanta, Georgia, United States • Harare, Zimbabwe

COMPLETEDPhase 3

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

NCT00524368

The purpose of this study is to test if being treated with darunavir/ritonavir (DRV/rtv) 800/100 mg daily is as effective as being treated with DRV/rtv 600/100 mg twice daily, in early antiretroviral (ARV)-experienced patients when given along with selected optimized background regimen (OBR).

Human Immunodeficiency Virus - Type 1

Tibotec Pharmaceuticals, Ireland590 participantsStarted Oct 2007

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Beverly Hills, California, United States +82 more locations

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

Related Searches

Exploration of HIV Reservoirs

Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy

Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women

Development of a Methamphetamine Early Intervention

Mobile Phone Text Messaging Referral

TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278

A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

HIV and Cardiovascular Risk

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Prevalence of Hepatitis C Virus Infection in HIV-Infected Children